Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth Factor Delivery (GF Delivery)
- Target
- GF Delivery
- Molecular classification
- Therapeutic strategy, Drug delivery system, Biomaterial-based delivery, Protein engineering
01
Overview
Growth factor delivery encompasses all methods developed for targeted administration of bioactive proteins that direct cell fate decisions during healing/regeneration processes. It is not a single molecule/receptor but rather an entire class of therapeutic strategies centered around optimizing how these potent signals are presented within living tissues for maximal clinical benefit with minimal risk. Strategies include the use of scaffolds, microspheres, nanoparticles, and stimuli-responsive systems to control the spatial and temporal release of growth factors.
- Other names
- Growth factor delivery systemsGrowth factor administrationTargeted growth factor therapy
02
Mechanism of action
Controlled release of growth factors to stimulate cellular activity and tissue regeneration at the target site.
03
Biological functions
Tissue regenerationCell proliferationCell migrationCell differentiationAngiogenesisOsteogenesisChondrogenesisLocalized drug release
04
Disease associations
Wound healingBone fracture repairCartilage repairVascular insufficiencyTissue engineering applicationsRegenerative medicine
05
Safety considerations
Ectopic tissue formation (e.g., ectopic bone formation with BMPs)Tumorigenesis (potential for uncontrolled cell proliferation)Immune response to delivery vehicle or growth factorOff-target effects due to systemic exposureProteolytic degradation of growth factorsShort half-life of growth factors
06
Interacting drugs
Bone morphogenetic proteins (BMPs)
4 more in the full profile.
07
Biomarkers
Growth factor concentration at the target siteCellular proliferation markers (e.g., Ki-67)Differentiation markers (e.g., osteocalcin for bone)Angiogenic markers (e.g., CD31)
Beyond the preview
Go deeper on Growth Factor Delivery (GF Delivery).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Growth Factor Delivery (GF Delivery).